Anzeige
Mehr »
Login
Dienstag, 24.09.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Die FED senkt die Zinsen, Gold explodiert: Die eine Aktie, die sie alle überstrahlen könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
247 Leser
Artikel bewerten:
(1)

Fact.MR: Software as a Medical Device Market to Surpass US$ 5.4 Billion by 2032 as Integration of Internet of Things in Healthcare Sector Surges

AI-Based Software as a Medical Device to Register Over 35% CAGR through 2022 & Beyond

The latest report on the software as a medical device market conducted by Fact.MR uncovers critical trends and opportunities across various key segments in terms of device type, software technology, application, and region between 2022 and 2032. The report emphasizes on providing exclusive insights into the market to assist key players in making well-knitted strategies to gain a competitive edge.

NEW YORK, Oct. 25, 2022 /PRNewswire/ -- The global software as a medical device (SaMD) market is expected to reach US$ 1.1 billion in 2022, registering 16.7% CAGR during the forecast period (2022-2032). Sales in the market are projected to surpass US$ 5.4 billion by 2032 as integration of artificial intelligence, and advanced technology is surging in healthcare sector.

Fact.MR Logo

Increasing use of Internet of things (IoT) in the healthcare industry and government efforts to improve the infrastructure are likely to drive the growth in software as a medical device market. Further, monitoring blood pressure, respiration rate, continual collecting of particular metrics in case of chronic conditions, and offering remote support are some of the functions of IoT in healthcare. As a result, the adoption of IoT in the healthcare industry will boost the expansion over the forecast period.

Software as a medical device enhances the effectiveness of medical devices and existing treatment programs, resulting in faster and higher-quality data collection and improved health outcomes. As these solutions are faster and less expensive to upgrade than hardware solutions, the demand in the U.S., the U.K., and other developed regions is expected to surge.

Ability to easily seek user input on host devices also contributes to shorter market time, faster product revisions, and faster innovation. As a result, the benefits provided by these solutions are projected to propel the growth in software as a medical device market over the decade.

Get A Free Sample Copy of this Report!
https://www.factmr.com/connectus/sample?flag=S&rep_id=7679

Regionally, Asia Pacific software as a medical device market will witness significant growth as a result of quick regulatory changes in medical devices and favorable policies across China and India. Furthermore, adequate government rules for developers regarding the design of diagnostics and medical devices are expected to boost the market.

The market for software as a medical device was dominated by PCs and laptops, in terms of device type. The segment is likely to maintain its dominance during the projection period due to technological advancements in laptop designs that enable the installation of smart sensors, which is transforming the compatibility between these devices and the SaMD.

Key Takeaways:

  • North America software as a medical device market is expected to register 15.8% CAGR between 2022 and 2032.
  • Based on software technology, the artificial intelligence (AI) segment grew at a CAGR of more than 35% over the past decade.
  • The U. S is expected to account for a demand share of 90.2% in North America software as a medical device market.
  • Japan software as a medical device market is predicted to grow at a CAGR of 17.8% over the upcoming decade.
  • Chronic illness and disease management application market will grow by 5.2x between 2022 and 2032.
  • Based on application, screening and diagnosis will hold a market share of 53.4% in 2022.

Growth Drivers:

  • Introduction of AI-based software applications and the advancement of technology will drive the growth in software as a medical device market.
  • The adoption of software as medical devices has substantially enhanced market growth due to the simplicity of handling and faster decision-making.

Restraints:

  • Expansion is likely to be hampered by increasing instances of cybercrime and a lack of cybersecurity, which may impede earning consumer confidence.
  • Growth of software as a medical device is hampered by their intangible character, which allows for many copies and wide distribution.

Get Customization on this Report for Specific Research Solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7679

Competitive Landscape:

To maintain their position, key players in the software as a medical device market are adopting organic growth techniques such as new developments and launches. Players in the market are focusing on increasing their capacity as well as their worldwide presence, employing both organic and inorganic growth strategies including acquisitions and partnerships.

For instance,

  • In 2022, iCAD, Inc., a global medical technology company offering novel cancer detection and therapeutic solutions, announced today the introduction of a new webinar series, ProFound Insights, ProFound Impact, which will feature client success stories throughout the year.
  • In 2022, Hyperfine, Inc., the manufacturer of Swoop, the first FDA-cleared portable magnetic resonance imaging (MRI) systemTM, is pleased to announce that Queen's University and Kingston Health Sciences Centre will deploy a Swoop system as part of their health services for six towns in the James Bay and Hudson Bay Area.
  • In December 2020, MaxQ AI, Ltd. has developed a second-generation ACCIPIO clinical platform for the healthcare sector in order to help physicians give "smarter care" through improved clinical workflow.

Key Companies Profiled by Fact.MR

  • GE Healthcare
  • iCAD Inc.
  • Hyperfine Research
  • Star
  • Tietronix Software, Inc.
  • S3 Connected Health
  • Ideagen
  • BrightInsight, Inc
  • Inzentiz
  • Zühlke Group
  • Orthogonal

More Valuable Insights on Software as a Medical Device Market

In the latest study, Fact.MR offers a detailed study on global software as a medical device market for the forecast period of 2022 to 2032. This study also highlights key drivers promoting the sales of software as a medical device through detailed segmentation as follows:

By Device Type:

  • Smartphones
  • Laptops/Desktops
  • Wearable Devices

By Software Technology:

  • Artificial Intelligence
  • Machine Learning

By Application:

  • Screening and Diagnosis
  • Monitoring and Alerting
  • Chronic Condition & Disease Management
  • Digital Therapeutics

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA

Choose Quick and Secure PayPal Payment Mode to Get Full Access of This Report
https://www.factmr.com/checkout/7679

Key Questions Covered in the Software as a Medical Device Market Report

  • What is the projected value of the software as a medical device market in 2022?
  • At what rate will the global software as a medical device market grow until 2032?
  • Which are the factors hampering the growth in the software as a medical device market?
  • Which region is expected to lead in the global software as a medical device market during 2022-2032?
  • Which are the factors driving the software as a medical device market during the forecast period?

Explore Fact.MR's Coverage on the Technology Domain

Software Defined Perimeter Market: The global software defined perimeter market is projected to reach US$ 28.2 Billion in 2032 and exhibit growth at a CAGR of 14.3% in the forecast period from 2022 to 2032. Cloud services and mobile enterprise solutions are gaining popularity in the industry, which will accelerate growth.

Clientless Remote Support Software Market: The global clientless remote support software market size is poised to grow at a CAGR of 14.5% between 2022 and 2032, reaching a valuation of US$ 6.7 billion by 2032. As cloud-based software services and support software for training become more popular, solution suppliers of clientless remote assistance software could benefit from increased business prospects.

Public Safety Software Market: Fact.MR predicts the global public safety software market to reach US$ 20 billion by 2031 and showcase growth at a CAGR of 9% between 2021 and 2031. The market for public safety software is expanding thanks to an increase in both criminal activity and natural disasters.

Check it Out More Reports by Fact.MR on Technology Industry
https://www.factmr.com/industry/technology

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. We are committed to deliver insights that help businesses gain deeper understanding of their target markets. We understand that making sense of the vast labyrinth of data can be overwhelming for businesses. That's why focus on offering insights that can actually make a difference to bottom-lines.

Specialties: Competition Tracking, Customized Research, Syndicated Research, Investment Research, Social Media Research, Business Intelligence, Industry Analysis, Thought Leadership.

Contact:

Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
E: sales@factmr.com

Follow Us: LinkedIn | Twitter | YouTube

Logo: https://mma.prnewswire.com/media/713666/FactMR_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/software-as-a-medical-device-market-to-surpass-us-5-4-billion-by-2032-as-integration-of-internet-of-things-in-healthcare-sector-surges-301658267.html

© 2022 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.